Adhering to the vision of "building a world-class biopharmaceutical enterprise", Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.(hereinafter referred to as " NKF ")is about to make its appearance at the "barometer" exhibition of the global pharmaceutical industry - CPHI Worldwide Europe, and join hands with global partners to attend this industry event!
The exhibition will be grandly held at Messe Frankfurt GmbH, Messeplatz 1, 60327 Frankfurt am Main, Germany from October 28th to 30th, 2025.
As a top brand exhibition in the international pharmaceutical raw materials field, CPHI Worldwide is not only a professional exchange platform for pharmaceutical raw materials and intermediates, but also, with its continuous increase in influence and the upgrading of customer demands, has extended into an important cooperation carrier in the field of pharmaceutical preparations. Here, one can not only obtain the latest technology and product information in the industry at close range, but also gain insights into the development trends of the global pharmaceutical industry. It serves as the core window for enterprises to connect with global resources.
Booth:3.0 F32
We sincerely invite you to visit our NKF Booth (Booth: 3.0F32)
From Chinese innovation to global sharing, NKF is willing to join hands with global pharmaceutical enterprises and partners to forge ahead and create a trustworthy future for the pharmaceutical industry!
Regarding NKF Shares：
NKF is a pharmaceutical group enterprise integrating the research and development, production and sales of drugs. It was listed on the A-share market of the Shanghai Stock Exchange on July 19, 2017.
We possess a globally leading isolator production line, high-end sterile injection production technology, and a global quality system that has been certified by multiple regions including China, the United States, Europe, Japan, and Brazil. With world-class production and R&D speed, global quality awareness, and sales capabilities rooted in the United States, it can also provide CDMO services for injectables centered on the Chinese and American markets and covering the entire world.NKF gathers global innovative talents, promotes the company's move towards innovative internationalization, and builds a world-class biopharmaceutical company.
